Type 1 Diabetes and Dysfunctional Intestinal Homeostasis

Francesca D'Addio, Paolo Fiorina

Research output: Contribution to journalArticle

Abstract

Despite the relatively high frequency of gastrointestinal (GI) disorders in individuals with type 1 diabetes (T1D), termed diabetic enteropathy (DE), the pathogenic mechanisms of these disorders remain to be elucidated. While previous studies have assumed that DE is a manifestation of diabetic autonomic neuropathy, other contributing factors such as enteric hormones, inflammation, and microbiota were later recognized. More recently, the emerging role of intestinal stem cells (ISCs) in several GI diseases has led to a new understanding of DE. Given the absence of diagnostic methods and the lack of broadly efficacious therapeutic remedies in DE, targeting factors and pathways that control ISC homeostasis and are dysfunctional in DE may represent a new path for the detection and cure of DE. Diabetes is a multiorgan disease that also targets the gastrointestinal (GI) tract, leading to the development of diabetic enteropathy (DE).DE is poorly characterized thus far, despite its high frequency in both type 1 and type 2 diabetic individuals.Recent evidence suggests that DE as well as other GI diseases may arise due to an alteration in intestinal stem cell (ISC) homeostasis.Because few diagnostic and therapeutic approaches are available in DE, targeting novel mechanisms of disease such as disruption of ISCs is essential.Considering the difficulties encountered by cell therapy, targeting hormonal-like axes that control ISCs and their homeostasis, such as with ecto-TMEM219, may represent a novel strategy to treat GI diseases and DE.

Original languageEnglish
JournalTrends in Endocrinology and Metabolism
DOIs
Publication statusAccepted/In press - 2016

Fingerprint

Type 1 Diabetes Mellitus
Homeostasis
Stem Cells
Gastrointestinal Diseases
Gastrointestinal Hormones
Diabetic Neuropathies
Microbiota
Cell- and Tissue-Based Therapy
Gastrointestinal Tract
Inflammation
Therapeutics

Keywords

  • Circulating enterotrophic hormones
  • Diabetic enteropathy
  • Gastrointestinal disorders
  • Intestinal stem cells

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Type 1 Diabetes and Dysfunctional Intestinal Homeostasis. / D'Addio, Francesca; Fiorina, Paolo.

In: Trends in Endocrinology and Metabolism, 2016.

Research output: Contribution to journalArticle

@article{c61458d0cff9477db8a90b5604dbe759,
title = "Type 1 Diabetes and Dysfunctional Intestinal Homeostasis",
abstract = "Despite the relatively high frequency of gastrointestinal (GI) disorders in individuals with type 1 diabetes (T1D), termed diabetic enteropathy (DE), the pathogenic mechanisms of these disorders remain to be elucidated. While previous studies have assumed that DE is a manifestation of diabetic autonomic neuropathy, other contributing factors such as enteric hormones, inflammation, and microbiota were later recognized. More recently, the emerging role of intestinal stem cells (ISCs) in several GI diseases has led to a new understanding of DE. Given the absence of diagnostic methods and the lack of broadly efficacious therapeutic remedies in DE, targeting factors and pathways that control ISC homeostasis and are dysfunctional in DE may represent a new path for the detection and cure of DE. Diabetes is a multiorgan disease that also targets the gastrointestinal (GI) tract, leading to the development of diabetic enteropathy (DE).DE is poorly characterized thus far, despite its high frequency in both type 1 and type 2 diabetic individuals.Recent evidence suggests that DE as well as other GI diseases may arise due to an alteration in intestinal stem cell (ISC) homeostasis.Because few diagnostic and therapeutic approaches are available in DE, targeting novel mechanisms of disease such as disruption of ISCs is essential.Considering the difficulties encountered by cell therapy, targeting hormonal-like axes that control ISCs and their homeostasis, such as with ecto-TMEM219, may represent a novel strategy to treat GI diseases and DE.",
keywords = "Circulating enterotrophic hormones, Diabetic enteropathy, Gastrointestinal disorders, Intestinal stem cells",
author = "Francesca D'Addio and Paolo Fiorina",
year = "2016",
doi = "10.1016/j.tem.2016.04.005",
language = "English",
journal = "Trends in Endocrinology and Metabolism",
issn = "1043-2760",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Type 1 Diabetes and Dysfunctional Intestinal Homeostasis

AU - D'Addio, Francesca

AU - Fiorina, Paolo

PY - 2016

Y1 - 2016

N2 - Despite the relatively high frequency of gastrointestinal (GI) disorders in individuals with type 1 diabetes (T1D), termed diabetic enteropathy (DE), the pathogenic mechanisms of these disorders remain to be elucidated. While previous studies have assumed that DE is a manifestation of diabetic autonomic neuropathy, other contributing factors such as enteric hormones, inflammation, and microbiota were later recognized. More recently, the emerging role of intestinal stem cells (ISCs) in several GI diseases has led to a new understanding of DE. Given the absence of diagnostic methods and the lack of broadly efficacious therapeutic remedies in DE, targeting factors and pathways that control ISC homeostasis and are dysfunctional in DE may represent a new path for the detection and cure of DE. Diabetes is a multiorgan disease that also targets the gastrointestinal (GI) tract, leading to the development of diabetic enteropathy (DE).DE is poorly characterized thus far, despite its high frequency in both type 1 and type 2 diabetic individuals.Recent evidence suggests that DE as well as other GI diseases may arise due to an alteration in intestinal stem cell (ISC) homeostasis.Because few diagnostic and therapeutic approaches are available in DE, targeting novel mechanisms of disease such as disruption of ISCs is essential.Considering the difficulties encountered by cell therapy, targeting hormonal-like axes that control ISCs and their homeostasis, such as with ecto-TMEM219, may represent a novel strategy to treat GI diseases and DE.

AB - Despite the relatively high frequency of gastrointestinal (GI) disorders in individuals with type 1 diabetes (T1D), termed diabetic enteropathy (DE), the pathogenic mechanisms of these disorders remain to be elucidated. While previous studies have assumed that DE is a manifestation of diabetic autonomic neuropathy, other contributing factors such as enteric hormones, inflammation, and microbiota were later recognized. More recently, the emerging role of intestinal stem cells (ISCs) in several GI diseases has led to a new understanding of DE. Given the absence of diagnostic methods and the lack of broadly efficacious therapeutic remedies in DE, targeting factors and pathways that control ISC homeostasis and are dysfunctional in DE may represent a new path for the detection and cure of DE. Diabetes is a multiorgan disease that also targets the gastrointestinal (GI) tract, leading to the development of diabetic enteropathy (DE).DE is poorly characterized thus far, despite its high frequency in both type 1 and type 2 diabetic individuals.Recent evidence suggests that DE as well as other GI diseases may arise due to an alteration in intestinal stem cell (ISC) homeostasis.Because few diagnostic and therapeutic approaches are available in DE, targeting novel mechanisms of disease such as disruption of ISCs is essential.Considering the difficulties encountered by cell therapy, targeting hormonal-like axes that control ISCs and their homeostasis, such as with ecto-TMEM219, may represent a novel strategy to treat GI diseases and DE.

KW - Circulating enterotrophic hormones

KW - Diabetic enteropathy

KW - Gastrointestinal disorders

KW - Intestinal stem cells

UR - http://www.scopus.com/inward/record.url?scp=84966716353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84966716353&partnerID=8YFLogxK

U2 - 10.1016/j.tem.2016.04.005

DO - 10.1016/j.tem.2016.04.005

M3 - Article

AN - SCOPUS:84966716353

JO - Trends in Endocrinology and Metabolism

JF - Trends in Endocrinology and Metabolism

SN - 1043-2760

ER -